Tamponade in surgery for retinal detachment associated with proliferative vitreoretinopathy

Cochrane Database of Systematic Reviews

Volumn , Issue 4, 2009, Pages

  Schwartz, Stephen G ^a   Flynn Jr , Harry W ^a   Lee, Wen Hsiang ^a   Ssemanda, Elizabeth ^b   Ervin, Ann Margret ^b  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Fluorocarbons *administration dosage ; Humans; Randomized controlled trials as topic; Recurrence prevention control ; Retinal detachment etiology; prevention control; *therapy ; Silicone oils *administration dosage ; Sulfur hexafluoride * administration dosage ; Vitreoretinopathy, proliferative *complications

Indexed keywords

PERFLUTREN; SILICONE OIL; SULFUR HEXAFLUORIDE;

CILIARY DISK; CLINICAL TRIAL; HUMAN; RETINA DETACHMENT; REVIEW; TREATMENT OUTCOME; VITRECTOMY; VITREORETINOPATHY;

EID: 77950136382     PISSN: 1469493X     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD006126.pub2     Document Type: Review

References (56)

1. Silicone Study 1992a {published data only} Abrams GW, Azen SP, Barr CC, Lai MY, Hutton WL, Trese MT, et al.The incidence of corneal abnormalities in the Silicone Study. Silicone Study Report 7. Archives of Ophthalmology 1995;113(6):764-9.
2. Abrams GW, Azen SP, McCuen BW 2nd, Flynn HW Jr, Lai MY, Ryan SJ. Vitrectomy with silicone oil or long-acting gas in eyes with severe proliferative vitreoretinopathy: results of additional and long-term follow-up. Silicone Study report 11. Archives of Ophthalmology 1997;115(3): 335-43.
3. * Anonymous. Vitrectomy with silicone oil or sulfur hexafluoride gas in eyes with severe proliferative vitreoretinopathy: results of a randomized clinical trial. Silicone Study Report 1. Archives of Ophthalmology 1992;110(6):770-9.
4. Azen SP, Boone DC, Barlow W, McCuen BW, Walonker AF, Anderson MM, et al.Methods, statistical features, and baseline results of a standardized, multicentered ophthalmologic surgical trial: the Silicone Study. Controlled Clinical Trials 1991;12(3):438-55.
5. Barr CC, Lai MY, Lean JS, Linton KL, Trese M, Abrams G, et al.Postoperative intraocular pressure abnormalities in the Silicone Study. Silicone Study Report 4. Ophthalmology 1993;100(11):1629-35.
6. Blumenkranz MS, Azen SP, Aaberg T, Boone DC, Lewis H, Radtke N, et al.Relaxing retinotomy with silicone oil or long-acting gas in eyes with severe proliferative vitreoretinopathy. Silicone Study Report 5. The Silicone Study Group. American Journal of Ophthalmology 1993;116(5):557-64.
7. Brown GC, Brown MM, Sharma S, Busbee B, Landy J. A costutility analysis of interventions for severe proliferative vitreoretinopathy. American Journal of Ophthalmology 2002;133(3):365-71.
8. Cox MS, Azen SP, Barr CC, Linton KL, Diddie KR, Lai MY, et al.Macular pucker after successful surgery for proliferative vitreoretinopathy. Silicone Study Report 8. Ophthalmology 1995;102(12):1884-91.
9. Diddie KR, Azen SP, Freeman HM, Boone DC, Aaberg TM, Lewis H. Anterior proliferative vitreoretinopathy in the silicone study. Silicone Study Report Number 10. Ophthalmology 1996;103(7):1092-9.
10. Hutton WL, Azen SP, Blumenkranz MS, Lai MY, McCuen BW, Han DP, et al.The effects of silicone oil removal. Silicone Study Report 6. Archives of Ophthalmology 1994 Jun;112(6):778-85.
11. Lean J, Azen SP, Lopez PF, Qian D, Lai MY, McCuen B. The prognostic utility of the Silicone Study Classification System. Silicone Study Report 9. Silicone Study Group. Archives of Ophthalmology 1996;114(3):286- 92.
12. McCuen BW 2nd, Azen SP, Stern W, Lai MY, Lean JS, Linton KL, et al.Vitrectomy with silicone oil or perfluoropropane gas in eyes with severe proliferative vitreoretinopathy. Silicone Study Report 3. Retina 1993;13(4):279-84.
13. Silicone Study 1992b {published data only} Anonymous. Vitrectomy with silicone oil or perfluoropropane gas in eyes with severe proliferative vitreoretinopathy: results of a randomized clinical trial. Silicone Study Report 2. Archives of Ophthalmology 1992;110(6): 780-92.
14. Avci 2001 {published data only} Avci R. Cataract surgery and transpupillary silicone oil removal through a single scleral tunnel incision under topical anesthesia; sutureless surgery. International Ophthalmology 2001;24(6):337-41.
15. Brazitikos 2005 {published data only} Brazitikos PD, Androudi S, Christen WG, Stangos NT. Primary pars plana vitrectomy versus scleral buckle surgery for the treatment of pseudophakic retinal detachment: a randomized clinical trial. Retina 2005;25(8):957-64.
16. Gao 1993 {published data only} Gao R, Lu L, Zhang S, Tang S, Liu Q, Hu Z. Study on application of the silicone oil in the reattachment of complicated retinal detachment. Yan Ke Xue Bao [Eye Science] 1993;9(3):146-8.
17. Hammer 1997 {published data only} Hammer M,Margo CE, Grizzard WS. Complex retinal detachment treated with silicone oil or sulfur hexafluoride gas: a randomized clinical trial. Ophthalmic Surgery & Lasers 1997;28(11):926-31.
18. Hutchins 2003 {published data only} Hutchins RK, Kaufman AH, Augsburger JJ. Perfluoro-octane internal tamponade when using a temporary keratoprosthesis during retinal detachment repair. Retina 2003;23(1):106-10.
19. Krasnik 1999 {published data only} Krásnik V, Strmen P, Furdová A, Hasa J. Ultrasonic diagnosis of retinal detachment after internal tamponade with silicone oil [Ultrazvukova diagnostika amocie sietnice po vnutornej tamponade silikonovym olejom]. Ceska a Slovenska Oftalmologie 1998;54(5):305-9.
20. Latecka-Krajewska 1998 {published data only} Latecka-Krajewska B, Nawrocki J, Bogorodzki B. Usefulness of different silicone oils for intraocular tamponade [Ocena przydatnosci roznych rodzajow oleju sylikonowego do tamponady wewnatrzgalkowej]. Klinka Oczna 1998;100(5):295-300.
21. Li 1995 {published data only} Li X, Jiang Y, Zkang X. [A comparison of attachment rates between SF6 and silicone oil tamponades following vitrectomy for treatment of complicated retinal detachment]. Zhonghua Yan Ke Za Zhi [Chinese Journal of Ophthalmology] 1995;31(4):250-4.
22. Lu 2002 {published data only} Lu L, Li Y, Cai S, Yang J. Vitreous surgery in highly myopic retinal detachment resulting from a macular hole. Clinical & Experimental Ophthalmology 2002;30(4):261-5.
23. Pastor 1998 {published data only} Pastor JC, Zarco JM, Del Nozal MJ, Pampliega A, Marinero P. Clinical consequences of the use of highly purified silicone oil: Comparative study of highly and less purified silicone oil. European Journal of Ophthalmology 1998;8(3):179-83.
24. Pertile 1999 {published data only} Pertile G, Claes C. Silicone oil vs. gas for the treatment of full-thickness macular hole. Bulletin de la Société Belge d'Ophtalmologie 1999;274:31-6.
25. Peyman 1987 {published data only} Peyman GA, Kao GW, de Corral LR. Randomized clinical trial of intraocular silicone vs. gas in the management of complicated retinal detachment and vitreous hemorrhage. International Ophthalmology 1987;10(4):221-34.
26. Soheilian 2006 {published data only} Soheilian M, Mazareei M, Mohammadpour M, Rahmani B. Comparison of silicon oil removal with various viscosities after complex retinal detachment surgery. BMC Ophthalmology 2006;6:21.
27. Stefer 1991 {published data only} Stefer U, Wiedemann P, Weber J, Heimann K. Functional results after vitrectomy with silicone oil injection. European Journal of Ophthalmology 1991;1(2):89-95.
28. Tufail 1997 {published data only} Tufail A, Schwartz SD, Gregor ZJ. Prophylactic argon laser retinopexy prior to removal of silicone oil: a pilot study. Eye 1997;11(Pt 3):328-30.
29. van Effenterre 1987 {published data only} van Effenterre G, Haut J, Larricart P, Abi-Rached J, Vachet JM. Gas tamponade as a single technique in the treatment of retinal detachment: is vitrectomy needed? A comparative study of 120 cases. Graefes Archive for Clinical & Experimental Ophthalmology 1987;225(4):254-8.
30. Oncel 2006 {published data only} Oncel M, Acikalin B. Heavy silicone oil vs. standard silicone oil for the management of complicated retinal detachment: A prospective randomized study. American Academy of Ophthalmology 2006:301.
31. HSO Study {published data only} Joussen AM, Kirchhof B, Schrage N, Ocklenburg C, Hilgers RD. Heavy silicone oil versus standard silicone oil as vitreous tamponade in inferior PVR (HSO Study): design issues and implications. Acta Ophthalmologica Scandinavica 2007;85(6):623-30.
32. Charteris 2002 Charteris DG, Sethi CS, Lewis GP, Fisher SK. Proliferative vitreoretinopathy - developments in adjunctive treatment and retinal pathology. Eye 2002;16(4):369-74.
33. Cowley 1989 Cowley M, Conway BP, Campochiaro PA, Kaiser D, Gaskin H. Clinical risk factors for proliferative vitreoretinopathy. Archives of Ophthalmology 1989;107(8):1147-51.
34. Deeks 2008 Deeks JJ, Higgins JPT, Altman DG (editors). Chapter 9: Analysing data and undertaking meta-analyses. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.1 [updated September 2008]. The Cochrane Collaboration, 2008. Available from www.cochrane-handbook.org.
35. Eckardt 1990 Eckardt C, Schmidt D, Czank M. Intraocular tolerance to silicone oils of different specific gravities: an experimental study. Ophthalmologica 1990;201(3):133-9.
36. Glanville 2006 Glanville JM, Lefebvre C, Miles JN, Camosso-Stefinovic J. How to identify randomized controlled trials in MEDLINE: ten years on. Journal of the Medical Library Association 2006;94(2):130-6.
37. Heimann 2007 Heimann H, Bartz-Schmidt KU, Bornfeld N, Weiss C, Hilgers RD, Foerster MH. Scleral Buckling versus Primary Vitrectomy in Rhegmatogenous Retinal Detachment Study Group. Scleral buckling versus primary vitrectomy in rhegmatogenous retinal detachment: a prospective randomized multicenter clinical study. Ophthalmology 2007;114(12):2142-54.
38. Heimann 2008 Heimann H, Stappler T, Wong D. Heavy tamponade 1: a review of indications, use, and complications. Eye (London, England) 2008;22(10):1342-59.
39. Higgins 2008 Higgins JPT, Altman DG (editors). Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.1 [updated September 2008]. The Cochrane Collaboration, 2008. Available from www.cochrane-handbook.org.
40. Hoerauf 2005 Hoerauf H, Roider J, Kobuch K, Laqua H. Perfluorohexylethan (O62) as ocular endotamponade in complex vitreoretinal surgery. Retina 2005;25(4):479-88.
41. Kruger 2002 Kruger EF, Nguyen QD, Ramos-Lopez M, Lashkari K. Proliferative vitreoretinopathy after trauma. International Ophthalmology Clinics 2002;42(3):129-43.
42. Krzystolik 2000 Krzystolik MG, D'Amico DJ. Complications of intraocular tamponade: silicone oil versus intraocular gas. International Ophthalmology Clinics 2000;40(1):187-200.
43. Matteucci 2007 Matteucci A, Formisano G, Paradisi S, Carnovale-Scalzo G, Scorcia G, Caiazza S, et al.Biocompatibility assessment of liquid artificial vitreous replacements: relevance of in vitro studies. Survey of Ophthalmology 2007;52(3):289-99.
44. Patel 2004 Patel NN, Bunce C, Asaria RH, Charteris DG. Resources involved in managing retinal detachment complicated by proliferative vitreoretinopathy. Retina 2004;24(6):883-7.
45. Rofail 2005 Rofail M, Lee LR. Perfluoro-n-octane as a postoperative vitreoretinal tamponade in the management of giant retinal tears. Retina 2005;25(7):897-901.
46. Schwartz 2004 Schwartz SG, Mieler WF. Management of primary rhegmatogenous retinal detachment. Comprehensive Ophthalmology Update 2004;5:285-94.
47. Scott 2002 Scott IU, Murray TG, Flynn HW Jr, Feuer WJ, Schiffman JC. Perfluoron Study Group. Outcomes and complications associated with giant retinal tear management using perfluoro-n-octane. Ophthalmology 2002;109(10):1828-33.
48. Scott 2005 Scott IU, Flynn HW Jr, Murray TG, Smiddy WE, Davis JL, Feuer WJ. Outcomes of complex retinal detachment repair using 1000- vs 5000-centistoke silicone oil. Archives of Ophthalmology 2005;123(4):473-8.
49. Singh 1986 Singh AK, Glaser BM, Lemor M, Michels RG. Gravity-dependent distribution of retinal pigment epithelial cells dispersed into the vitreous cavity. Retina 1986;6(2):77-80.
50. Singh 2001 Singh J, Ramaesh K, Wharton SB, Cormack G, Chawla HB. Perfluorodecalin-induced intravitreal inflammation. Retina 2001;21(3):247-51.
51. Stappler 2008 Stappler T, Heimann H, Wong D, Gibran SK, Groenewald C, Pearce IA. Heavy tamponade 2 Densiron 68 in routine clinical practice: anatomical and functional outcomes of a consecutive case series. Eye (London, England) 2008;22(10):1360-5.
52. Sterne 2008 Sterne JAC, Egger M, Moher D (editors). Chapter 10: Addressing reporting biases. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.1 [updated September 2008]. The Cochrane Collaboration, 2008. Available from www.cochrane-handbook.org.
53. Tognetto 2005 Tognetto D, Minutola D, Sanguinetti G, Ravalico G. Anatomical and functional outcomes after heavy silicone oil tamponade in vitreoretinal surgery for complicated retinal detachment. A pilot study. Ophthalmology 2005;112(9):1574-8.
54. Tognetto 2008 Tognetto D, Lepori L, Lapasin R, Minutola D, Sanguinetti G, Michelone L, et al.A new heavy internal tamponade in vitreoretinal surgery: an in vitro study. Eye 2008;22(8):1082-8.
55. TRSTC 1983 Anonymous.The Retina Society Terminology Committee. The classification of retinal detachment with proliferative vitreoretinopathy. Ophthalmology 1983;90(2):121-5.
56. Young 2005 Young TA, D'Amico DJ. Controversies in proliferative vitreoretinopathy tamponade and pharmacologic agents. International Ophthalmology Clinics 2005;45(5):163-71.